Video - European Medical Journal

Continue

Videos

EMJ
Oncology
26 Aug 2015

The evolving role of chemotherapy for the management of advanced prostate cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Karim Fizazi, MD, PhD, of the Institut Gustave Roussy, Villejuif, France…
EMJ
Oncology
26 Aug 2015

Daratumumab for heavily pretreated multiple myeloma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Sagar Lonial, MD, of the Winship Cancer Institute, Emory University, Atlanta…
EMJ
Oncology
26 Aug 2015

Current clinical perspectives on targeted therapy and immunotherapy for melanoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Caroline Robert, MD, PhD, of Institut Gustave Roussy, Villejuif, France…
EMJ
Oncology
26 Aug 2015

ENDEAVOR: Phase 3 trial comparing carfilzomib versus bortezomib in relapsed multiple myeloma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Joseph R. Mikhael, MD, of Mayo Clinic, Scottsdale, AZ, discusses the…
EMJ
Oncology
26 Aug 2015

Phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Sumanta K. Pal, MD, of City of Hope Comprehensive Cancer Center, Duarte, CA…
EMJ
Oncology
26 Aug 2015

Frontline and relapsed treatment of follicular lymphoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting Jeremy S. Abramson, MD, of the Massachusetts General Hospital Cancer Center…
EMJ
Oncology
26 Aug 2015

The Conquer Cancer Foundation of the American Society of Clinical Oncology

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Julie M. Vose, MD, MBA, FASCO, of the University of Nebraska Medical Center…
EMJ
Oncology
26 Aug 2015

Evaluating sustained adherence to ibrutinib in previously treated CLL

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jacqueline Barrientos, MD, of North Shore-LIJ Cancer Institute, Lake Success…